Literature DB >> 16374649

Outcome predictors and complications in the management of intradural spinal tumours.

M D Jenkinson1, C Simpson, R S Nicholas, J Miles, G F G Findlay, T J D Pigott.   

Abstract

The results of the management of 115 patients with intradural spinal tumours are presented. Data was collected retrospectively from the case notes. Tumours were categorized as intramedullary or extramedullary for statistical analysis. Meningioma, schwannoma and ependymoma accounted for 70% of tumours. Complete macroscopic excision was achieved in 84% of extramedullary and 54% of intramedullary tumours. There were two post-operative deaths, one of which was secondary to methacillin-resistant staphylococcus aureus (MRSA) meningitis. Cerebrospinal fluid leak (10%) and meningitis (7%) were the commonest complications. Ninety-six percent of patients with extramedullary tumours improved or remained unchanged on the Frankel scale. In the intramedullary group, 82% remained unchanged or improved after treatment. Pre-operative functional status was a predictor of good post-operative function for intra- and extramedullary tumours and for intramedullary tumours a good post-operative Frankel score predicted long-term survival.

Entities:  

Mesh:

Year:  2005        PMID: 16374649      PMCID: PMC3489409          DOI: 10.1007/s00586-005-0902-x

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  25 in total

1.  Spinal intradural tumours: Part I--Extramedullary.

Authors:  W el-Mahdy; P J Kane; M P Powell; H A Crockard
Journal:  Br J Neurosurg       Date:  1999-12       Impact factor: 1.596

2.  Surgical outcome of intramedullary spinal cord ependymoma.

Authors:  K Ohata; T Takami; T Gotou; K El-Bahy; M Morino; M Maeda; Y Inoue; A Hakuba
Journal:  Acta Neurochir (Wien)       Date:  1999       Impact factor: 2.216

3.  Spinal cord ependymoma: radical surgical resection and outcome.

Authors:  Fadi Hanbali; Daryl R Fourney; Eric Marmor; Dima Suki; Laurence D Rhines; Jeffrey S Weinberg; Ian E McCutcheon; Ian Suk; Ziya L Gokaslan
Journal:  Neurosurgery       Date:  2002-11       Impact factor: 4.654

4.  Intramedullary spinal cord astrocytoma in adults: postoperative outcome.

Authors:  M S Kim; C K Chung; G Choe; I H Kim; H J Kim
Journal:  J Neurooncol       Date:  2001-03       Impact factor: 4.130

Review 5.  Spinal cord astrocytomas: presentation, management and outcome.

Authors:  J K Houten; P R Cooper
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

6.  Review of 36 cases of spinal cord meningioma.

Authors:  F Gezen; S Kahraman; Z Canakci; A Bedük
Journal:  Spine (Phila Pa 1976)       Date:  2000-03-15       Impact factor: 3.468

7.  Recurrence of benign spinal neoplasms.

Authors:  U Schick; G Marquardt; R Lorenz
Journal:  Neurosurg Rev       Date:  2001-03       Impact factor: 3.042

8.  Surgical outcome and prognostic factors of spinal intramedullary ependymomas in adults.

Authors:  Ung Kyu Chang; Woo Jin Choe; Sang Kee Chung; Chun Kee Chung; Hyun Jib Kim
Journal:  J Neurooncol       Date:  2002-04       Impact factor: 4.130

9.  Salvage chemotherapy for recurrent spinal cord ependymona.

Authors:  Marc C Chamberlain
Journal:  Cancer       Date:  2002-09-01       Impact factor: 6.860

10.  The impact of methicillin-resistant Staphylococcus aureus in a neurosurgical unit: a growing problem.

Authors:  Kanna K Gnanalingham; Ashraf Elsaghier; Christopher Kibbler; Colin Shieff
Journal:  J Neurosurg       Date:  2003-01       Impact factor: 5.115

View more
  16 in total

Review 1.  Top Ten Tips Palliative Care Clinicians Should Know About Spinal Tumors.

Authors:  Theresa Williamson; Brice Painter; Elizabeth P Howell; C Rory Goodwin
Journal:  J Palliat Med       Date:  2018-12-20       Impact factor: 2.947

2.  Delay in diagnosis of primary intradural spinal cord tumors.

Authors:  David Segal; Zvi Lidar; Akiva Corn; Shlomi Constantini
Journal:  Surg Neurol Int       Date:  2012-05-14

3.  Relationship of intraoperative ultrasound characteristics with pathological grades and Ki-67 proliferation index in intracranial gliomas.

Authors:  Ozdil Baskan; Gokalp Silav; Ramazan Sari; Ozlem Canoz; Ilhan Elmaci
Journal:  J Med Ultrason (2001)       Date:  2014-11-22       Impact factor: 1.314

Review 4.  Pharmacotherapy for adults with tumors of the central nervous system.

Authors:  Nina F Schor
Journal:  Pharmacol Ther       Date:  2008-11-27       Impact factor: 12.310

5.  Intraoperative ultrasound in spinal tumor surgery.

Authors:  Francesco Prada; Ignazio G Vetrano; Assunta Filippini; Massimiliano Del Bene; Alessandro Perin; Cecilia Casali; Federico Legnani; Marco Saini; Francesco DiMeco
Journal:  J Ultrasound       Date:  2014-06-07

6.  Back pain in patients with degenerative spine disease and intradural spinal tumor: what to treat? when to treat?

Authors:  David Bellut; Urs M Mutter; Martin Sutter; Andreas Eggspuehler; Anne F Mannion; François Porchet
Journal:  Eur Spine J       Date:  2013-12-31       Impact factor: 3.134

7.  Treatment of spinal cord tumors.

Authors:  Brian Vaillant; Monica Loghin
Journal:  Curr Treat Options Neurol       Date:  2009-07       Impact factor: 3.598

8.  Intramedullary medullocervical ependymoma--surgical treatment, functional recovery, and long-term outcome.

Authors:  Da Li; Shu-Yu Hao; Zhen Wu; Gui-Jun Jia; Li-Wei Zhang; Jun-Ting Zhang
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-09-27       Impact factor: 1.742

9.  Age at Diagnosis and Baseline Myelomalacia Sign Predict Functional Outcome After Spinal Meningioma Surgery.

Authors:  Johannes Wach; Mohammed Banat; Patrick Schuss; Erdem Güresir; Hartmut Vatter; Jasmin Scorzin
Journal:  Front Surg       Date:  2021-07-02

10.  Occipito-cervical fusion following gross total resection for the treatment of spinal extramedullary tumors in craniocervical junction: a retrospective case series.

Authors:  Hua Jiang; Juliang He; Xinli Zhan; Maolin He; Shaohui Zong; Zengming Xiao
Journal:  World J Surg Oncol       Date:  2015-09-18       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.